Stay updated on HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.

Latest updates to the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 along with a funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding notice was added. The site revision has been updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedShow glossary feature is now available, and the page shows updated metadata labels including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision label of v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4 instead of v3.3.3. The rest of the content appears unchanged.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page adds a Locations section with Alberta, British Columbia, Ontario, Gangwon-do, and Gyeongsangnam-do, and removes the corresponding location blocks; the HHS Vulnerability Disclosure link is also removed.SummaryDifference0.5%

- Check85 days agoChange DetectedRevision: v3.3.2 supersedes v3.3.1. No substantive study information or dates appear to have changed.SummaryDifference0.0%

Stay in the know with updates to HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.